Bacterial Metabolism of Arginine Mitchell Korzenovsky Iowa State College
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Peptide-Based Drug Discovery Tools for Protein Post-Translational Modifications
ANNALES UNIVERSITATIS TURKUENSIS UNIVERSITATIS ANNALES AI 642 Ville Eskonen Ville PEPTIDE-BASED DRUG DISCOVERY TOOLS FOR PROTEIN POST-TRANSLATIONAL MODIFICATIONS Ville Eskonen Painosalama Oy, Turku, Finland 2021 Finland Turku, Oy, Painosalama ISBN 978-951-29-8356-8 (PRINT) – ISBN 978-951-29-8357-5 (PDF) TURUN YLIOPISTON JULKAISUJA ANNALES UNIVERSITATIS TURKUENSIS ISSN 0082-7002 (Painettu/Print) SARJA – SER. AI OSA – TOM. 642 | ASTRONOMICA – CHEMICA – PHYSICA – MATHEMATICA | TURKU 2021 ISSN 2343-3175 (Sähköinen/Online) PEPTIDE-BASED DRUG DISCOVERY TOOLS FOR PROTEIN POST-TRANSLATIONAL MODIFICATIONS Ville Eskonen TURUN YLIOPISTON JULKAISUJA – ANNALES UNIVERSITATIS TURKUENSIS SARJA – SER. AI OSA – TOM. 642 | ASTRONOMICA - CHEMICA – PHYSICA – MATHEMATICA | TURKU 2021 University of Turku Faculty of Science Department of Chemistry Detection Technology Drug Research Doctoral programme Supervised by Docent Harri Härmä, Ph.D. Kari Kopra, Ph.D. Department of Chemistry Department of Chemistry University of Turku University of Turku Turku, Finland Turku, Finland Reviewed by Professor Michael Schäferling Erik Schaefer, Ph.D. Department of Chemical Engineering AssayQuant FH Münster Marlborough, MA, USA Münster, Germany Opponent Michael G. Weller, Ph.D. Federal Institute for Materials Research and Testing (BAM) Berlin, Germany The originality of this publication has been checked in accordance with the University of Turku quality assurance system using the Turnitin OriginalityCheck service. ISBN 978-951-29-8356-8 (PRINT) ISBN 978-951-29-8357-5 (PDF) ISSN 0082-7002 (Painettu/Print) ISSN 2343-3175 (Sähköinen/Online) Painosalama Oy, Turku, Finland 2021 UNIVERSITY OF TURKU Faculty of Sciences Department of Chemistry Ville Eskonen: Peptide-based Drug Discovery Tools for Protein Post- Translational Modifications Doctoral Dissertation, 121 pp. Drug Research Doctoral Programme (DRDP) February 2021 ABSTRACT Bringing a new drug to the market is an expensive and long process. -
Endogenous Metabolites: JHU NIMH Center Page 1
S. No. Amino Acids (AA) 24 L-Homocysteic acid 1 Glutaric acid 25 L-Kynurenine 2 Glycine 26 N-Acetyl-Aspartic acid 3 L-arginine 27 N-Acetyl-L-alanine 4 L-Aspartic acid 28 N-Acetyl-L-phenylalanine 5 L-Glutamine 29 N-Acetylneuraminic acid 6 L-Histidine 30 N-Methyl-L-lysine 7 L-Isoleucine 31 N-Methyl-L-proline 8 L-Leucine 32 NN-Dimethyl Arginine 9 L-Lysine 33 Norepinephrine 10 L-Methionine 34 Phenylacetyl-L-glutamine 11 L-Phenylalanine 35 Pyroglutamic acid 12 L-Proline 36 Sarcosine 13 L-Serine 37 Serotonin 14 L-Tryptophan 38 Stachydrine 15 L-Tyrosine 39 Taurine 40 Urea S. No. AA Metabolites and Conjugates 1 1-Methyl-L-histidine S. No. Carnitine conjugates 2 2-Methyl-N-(4-Methylphenyl)alanine 1 Acetyl-L-carnitine 3 3-Methylindole 2 Butyrylcarnitine 4 3-Methyl-L-histidine 3 Decanoyl-L-carnitine 5 4-Aminohippuric acid 4 Isovalerylcarnitine 6 5-Hydroxylysine 5 Lauroyl-L-carnitine 7 5-Hydroxymethyluracil 6 L-Glutarylcarnitine 8 Alpha-Aspartyl-lysine 7 Linoleoylcarnitine 9 Argininosuccinic acid 8 L-Propionylcarnitine 10 Betaine 9 Myristoyl-L-carnitine 11 Betonicine 10 Octanoylcarnitine 12 Carnitine 11 Oleoyl-L-carnitine 13 Creatine 12 Palmitoyl-L-carnitine 14 Creatinine 13 Stearoyl-L-carnitine 15 Dimethylglycine 16 Dopamine S. No. Krebs Cycle 17 Epinephrine 1 Aconitate 18 Hippuric acid 2 Citrate 19 Homo-L-arginine 3 Ketoglutarate 20 Hydroxykynurenine 4 Malate 21 Indolelactic acid 5 Oxalo acetate 22 L-Alloisoleucine 6 Succinate 23 L-Citrulline 24 L-Cysteine-glutathione disulfide Semi-quantitative analysis of endogenous metabolites: JHU NIMH Center Page 1 25 L-Glutathione, reduced Table 1: Semi-quantitative analysis of endogenous molecules and their derivatives by Liquid Chromatography- Mass Spectrometry (LC-TripleTOF “or” LC-QTRAP). -
Argininosuccinate Lyase Deficiency
©American College of Medical Genetics and Genomics GENETEST REVIEW Argininosuccinate lyase deficiency Sandesh C.S. Nagamani, MD1, Ayelet Erez, MD, PhD1 and Brendan Lee, MD, PhD1,2 The urea cycle consists of six consecutive enzymatic reactions that citrulline together with elevated argininosuccinic acid in the plasma convert waste nitrogen into urea. Deficiencies of any of these enzymes or urine. Molecular genetic testing of ASL and assay of ASL enzyme of the cycle result in urea cycle disorders (UCDs), a group of inborn activity are helpful when the biochemical findings are equivocal. errors of hepatic metabolism that often result in life-threatening However, there is no correlation between the genotype or enzyme hyperammonemia. Argininosuccinate lyase (ASL) catalyzes the activity and clinical outcome. Treatment of acute metabolic decom- fourth reaction in this cycle, resulting in the breakdown of arginino- pensations with hyperammonemia involves discontinuing oral pro- succinic acid to arginine and fumarate. ASL deficiency (ASLD) is the tein intake, supplementing oral intake with intravenous lipids and/ second most common UCD, with a prevalence of ~1 in 70,000 live or glucose, and use of intravenous arginine and nitrogen-scavenging births. ASLD can manifest as either a severe neonatal-onset form therapy. Dietary restriction of protein and dietary supplementation with hyperammonemia within the first few days after birth or as a with arginine are the mainstays in long-term management. Ortho- late-onset form with episodic hyperammonemia and/or long-term topic liver transplantation (OLT) is best considered only in patients complications that include liver dysfunction, neurocognitive deficits, with recurrent hyperammonemia or metabolic decompensations and hypertension. -
Chemical Name Federal P Code CAS Registry Number Acutely
Acutely / Extremely Hazardous Waste List Federal P CAS Registry Acutely / Extremely Chemical Name Code Number Hazardous 4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro- P059 76-44-8 Acutely Hazardous 6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10- hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide P050 115-29-7 Acutely Hazardous Methanimidamide, N,N-dimethyl-N'-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]- P197 17702-57-7 Acutely Hazardous 1-(o-Chlorophenyl)thiourea P026 5344-82-1 Acutely Hazardous 1-(o-Chlorophenyl)thiourea 5344-82-1 Extremely Hazardous 1,1,1-Trichloro-2, -bis(p-methoxyphenyl)ethane Extremely Hazardous 1,1a,2,2,3,3a,4,5,5,5a,5b,6-Dodecachlorooctahydro-1,3,4-metheno-1H-cyclobuta (cd) pentalene, Dechlorane Extremely Hazardous 1,1a,3,3a,4,5,5,5a,5b,6-Decachloro--octahydro-1,2,4-metheno-2H-cyclobuta (cd) pentalen-2- one, chlorecone Extremely Hazardous 1,1-Dimethylhydrazine 57-14-7 Extremely Hazardous 1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4,4a,5,6,7,8,8a-octahydro-1,4-endo-endo-5,8- dimethanonaph-thalene Extremely Hazardous 1,2,3-Propanetriol, trinitrate P081 55-63-0 Acutely Hazardous 1,2,3-Propanetriol, trinitrate 55-63-0 Extremely Hazardous 1,2,4,5,6,7,8,8-Octachloro-4,7-methano-3a,4,7,7a-tetra- hydro- indane Extremely Hazardous 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]- 51-43-4 Extremely Hazardous 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, P042 51-43-4 Acutely Hazardous 1,2-Dibromo-3-chloropropane 96-12-8 Extremely Hazardous 1,2-Propylenimine P067 75-55-8 Acutely Hazardous 1,2-Propylenimine 75-55-8 Extremely Hazardous 1,3,4,5,6,7,8,8-Octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran Extremely Hazardous 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime 26419-73-8 Extremely Hazardous 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime. -
Amino Acid Metabolism, Urea Cycle Semester Iv, Paper Cc8
AMINO ACID METABOLISM, UREA CYCLE SEMESTER IV, PAPER CC8 UREA CYCLE + Some of the NH4 formed in the breakdown of amino acids is consumed in the biosynthesis of nitrogen compounds. Most aquatic species, such as the bony fishes, are ammonotelic, excreting amino nitrogen as ammonia. The toxic ammonia is simply diluted in the surrounding water. Most terrestrial animals are ureotelic, excreting amino nitrogen in the form of urea; birds and reptiles are uricotelic, excreting amino nitrogen as uric acid. In ureotelic organisms, the ammonia deposited in the mitochondria of hepatocytes is converted to urea in the urea cycle. This pathway was discovered in 1932 by Hans Krebs. The urea cycle begins inside liver mitochondria, but three of the subsequent steps take place in the cytosol. The first amino group to enter the urea cycle is derived from ammonia in the mitochondrial matrix arising from various amino acids. The urea cycle begins with the coupling of free NH4 + with HCO3- to form carbamoyl phosphate. The synthesis of carbamoyl phosphate, though a simple molecule, is complex, comprising three steps, all catalyzed by carbamoyl phosphate synthetase. - The reaction begins with the phosphorylation of HCO3 to form carboxyphosphate, which then reacts with ammonium ion to form carbamic acid. Finally, a second molecule of ATP phosphorylates carbamic acid to carbamoyl phosphate. The consumption of two molecules of ATP makes this synthesis of carbamoyl phosphate essentially irreversible. Next, the carbamoyl group of carbamoyl phosphate, which has a high transfer potential because of its anhydride bond, is transferred to ornithine to form citrulline, in a reaction catalyzed by + ornithine transcarbamoylase. -
Ammonium Carbamate Hazard Summary Identification
Common Name: AMMONIUM CARBAMATE CAS Number: 1111-78-0 RTK Substance number: 0091 DOT Number: NA 9083 Date: January 1996 Revision: March 2002 ------------------------------------------------------------------------- ------------------------------------------------------------------------- HAZARD SUMMARY WORKPLACE EXPOSURE LIMITS * Ammonium Carbamate can affect you when breathed in. The following exposure limits are for Ammonia: * Exposure can irritate the skin and eyes causing redness and tearing. OSHA: The legal airborne permissible exposure limit * Breathing Ammonium Carbamate can irritate the nose, (PEL) is 50 ppm averaged over an 8-hour throat and lungs causing coughing and/or shortness of workshift. breath. NIOSH: The recommended airborne exposure limit is IDENTIFICATION 25 ppm averaged over a 10-hour workshift and Ammonium Carbamate is a white crystalline (sand-like) 35 ppm, not to be exceeded during any 15 minute powder. It is used as a fertilizer and ammoniating agent. work period. REASON FOR CITATION ACGIH: The recommended airborne exposure limit is 25 ppm averaged over an 8-hour workshift and * Ammonium Carbamate is on the Hazardous Substance 35 ppm as a STEL (short-term exposure limit). List because it is cited by DOT and EPA. * Definitions are provided on page 5. WAYS OF REDUCING EXPOSURE HOW TO DETERMINE IF YOU ARE BEING * Where possible, enclose operations and use local exhaust ventilation at the site of chemical release. If local exhaust EXPOSED ventilation or enclosure is not used, respirators should be The New Jersey Right to Know Act requires most employers worn. to label chemicals in the workplace and requires public * Wear protective work clothing. employers to provide their employees with information and * Wash thoroughly immediately after exposure to training concerning chemical hazards and controls. -
TR-541: Formamide (CASRN 75-12-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies)
NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF FORMAMIDE (CAS NO. 75-12-7) IN F344/N RATS AND B6C3F1 MICE (GAVAGE STUDIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 July 2008 NTP TR 541 NIH Publication No. 08-5884 National Institutes of Health Public Health Service U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES FOREWORD The National Toxicology Program (NTP) is an interagency program within the Public Health Service (PHS) of the Department of Health and Human Services (HHS) and is headquartered at the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH). Three agencies contribute resources to the program: NIEHS/NIH, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (NIOSH/CDC), and the National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA). Established in 1978, the NTP is charged with coordinating toxicological testing activities, strengthening the science base in toxicology, developing and validating improved testing methods, and providing information about potentially toxic substances to health regulatory and research agencies, scientific and medical communities, and the public. The Technical Report series began in 1976 with carcinogenesis studies conducted by the National Cancer Institute. In 1981, this bioassay program was transferred to the NTP. The studies described in the Technical Report series are designed and conducted to characterize and evaluate the toxicologic potential, including carcinogenic activity, of selected substances in laboratory animals (usually two species, rats and mice). Substances selected for NTP toxicity and carcinogenicity studies are chosen primarily on the basis of human exposure, level of production, and chemical structure. -
The First Neonatal Case of Neonatal Argininosuccinic Aciduria in Korea
J Korean Soc Neonatol • 2011;18:143-137 Case report doi: 10.5385/jksn.2011.18.1.143 pISSN 1226-1513•eISSN 2093-7849 The First Neonatal Case of Neonatal Argininosuccinic Aciduria in Korea In Ok Hwang, M.D. and Eun Sil Lee, M.D.* Department of Pediatrics, Gumi CHA Hospital, CHA University College of Medicine, Seongnam, Department of Pediatrics*, College of Medicine, Yeungnam University, Daegu, Korea Argininosuccinic aciduria (ASAuria) is a rare autosomal recessive urea cycle disorder. Neonatal presentation of ASAuria is the most common form. It is characterized by lethargy, feeding intolerance, decreased consciousness, and coma after 24 to 72 hours of birth. We describe a rare case of ASAuria in a female neonate who presented with severe hyperammonemia, a typical character- istic of urea cycle disorders. This patient’s diagnosis was confirmed by biochemical analyses, and we found that the patient had a point mutation of the argininosuccinate lyase gene, which was homozygous for a novel 556C>T substitution. We have never seen the neonatal form of ASAuria in Korea. Therefore, this is the first report of neonatal onset ASAuria in Korea. Key Words: Argininosuccinic aciduria, Argininosuccinate lyase, Newborn Introduction retardation, intermittent ataxia, episodic hyperammonemia, and longer survival than the neonatal form. Argininosuccinic aciduria is a rare autosomal recessive ASAuria is rare in Asia, and no case has ever been reported inborn error of the urea cycle, characterized by accu in the newborn period in Korea. However, Ban et al.1) mulation of argininosuccinic acid (ASA) in body fluids and documented only anesthetic experience, not the process of hyperammonemia caused by argininosuccinate lyase (ASL) diagnosing argininosuccinic acidemia. -
Molecular Docking Studies of Natural Compounds of Naringin on Enzymes Involved in the Urea Cycle Pathway in Hyperammonemia
Arumugam et al Tropical Journal of Pharmaceutical Research May 2020; 19 (5): 1037-1043 ISSN: 1596-5996 (print); 1596-9827 (electronic) © Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. Available online at http://www.tjpr.org http://dx.doi.org/10.4314/tjpr.v19i5.19 Original Research Article Molecular docking studies of natural compounds of naringin on enzymes involved in the urea cycle pathway in hyperammonemia Ramakrishnan Arumugam1, Renuka Mani2, Amalan Venkatesan1, Senthilmurugan Sengamalai3, Vijayakumar Natesan1*, Sung-Jin Kim4* 1Department of Biochemistry and Biotechnology, Annamalai University, Tamilnadu, India, 2Department of Biotechnology, Periyar University, Tamilnadu, India, 3Department of Zoology, Annamalai University, Tamilnadu, India, 4Department of Pharmacology and Toxicology, Metabolic Diseases Research Laboratory, School of Dentistry, Kyung Hee University, Republic of Korea *For correspondence: Email: [email protected], [email protected]; Tel: +82-2-961-0868, +91-04144-239343 Sent for review: 18 September 2019 Revised accepted: 16 April 2020 Abstract Purpose: To investigate the anti-hyperammonemic activity of naringin by molecular docking via in silico studies. Methods: Urea cycle proteins were docked to the natural compound naringin as well as a standard drug, sodium benzoate. Hydrogen bonds and binding energy were obtained using Catalytic Site Atlas and Cast P Finder Software Tool. Results: There were six urea cycle enzymes, including N-acetyl glutamate synthase, carbamoyl phosphate synthase I, ornithine transcarbamylase, argininosuccinate synthase, argininosuccinate lyase and arginase I. On evaluating protein interactions with naringin, which is dynamically connected to the urea cycle pathway with hyperammonemia, naringin showed more hydrogen bonds and also produced higher binding energy when compared to the standard drug, sodium benzoate. -
Quantitative Amino Acids Analysis for the Diagnosis and Follow up of Inborn Errors of Metabolism
Quantitative amino acids analysis for the diagnosis and follow up of inborn errors of metabolism Irene De Biase, MD, PhD, FACMG Assistant Professor of Pathology, University of Utah Medical Director, Biochemical Genetics and Supplemental Newborn Screening, ARUP Laboratories Conflict of Interest . None to declare Learning objectives o Define Inborn Errors of Metabolism (IEM) . Emphasis on disorders of amino acid metabolism and transport, and urea cycle disorders o Compare strengths and weaknesses among methods used to quantify physiological amino acids in body fluids o Evaluate the use of quantitative amino acid analysis for IEM diagnosis and follow-up Metabolism is sum of all chemical reactions that occur within an organism PROTEIN GLYCOGEN FAT FRUCTOSE GALACTOSE AMINO GLUCOSE FREE ACIDS FATTY ACIDS ORGANIC ACIDS PYRUVATE LACTATE AMMONIA ◄ ACETYL CoA UREA ► CYCLE KREBS KETONES CYCLE ► ◄ ATP UREA NADH (Energy) Pediatr Rev (1995) 16(10):390-5 Inborn errors of metabolism (IEM) Genetic disorders affecting metabolic pathways o Clinical signs and symptoms are caused by substrate accumulation, product deficiency, and/or alternative toxic byproducts A B Enzyme C Several mechanisms can contribute to the metabolic block in IEM ③ ④ A Feedback ① Enzyme defect ② Cofactor defects ③ Decreased transport A B D across membranes Enzyme Enzyme Y ① ④ Lack of feedback Cofactor ② ⑤ Secondary inhibition by C alternative byproducts ⑤ E F Most IEM are inherited as autosomal recessive disorders o Heterozygotes do not show any clinical manifestations . Mating between two heterozygotes has a 25% chance to produce an affect child IEM cumulative frequency is high approximately 1:2,000 o Individually, IEM are rare . PKU (phenylketonuria) 1:12,000 . -
Federal Register / Vol. 62, No. 116 / Tuesday, June 17, 1997 / Rules and Regulations
32974 Federal Register / Vol. 62, No. 116 / Tuesday, June 17, 1997 / Rules and Regulations ENVIRONMENTAL PROTECTION p.m. EST, toll-free, at 800±424±9346; standards for owners and operators of AGENCY 703±412±9810 from Government phones hazardous waste treatment, storage and or if in the Washington, DC local calling disposal facilitiesÐincluding standards 40 CFR Parts 261, 268, 271, and 302 area; or 800±553±7672 for the hearing for obtaining permitsÐare found at 40 impaired. For more detailed information CFR part 264. [EPA530±Z±97±FFF; FRL±5839±7] on specific aspects of the rulemaking, Hazardous wastes are also subject to RIN 2050±AD59 contact Caroline Gerwe by calling 703± land disposal restrictions under 40 CFR 308±3540 or by writing, to U.S. part 268. EPA's authorizations for state Hazardous Waste Management Environmental Protection Agency, hazardous waste programs are found at System; Carbamate Production, Office of Solid Waste, Hazardous Waste 40 CFR part 272. The requirements for Identification and Listing of Hazardous Identification Division, 401 M St., SW., obtaining these authorizations are found Waste; Land Disposal Restrictions; (Mailcode 5304W), Washington, DC at 40 CFR part 271. Authorization of State Hazardous 20460. In addition, hazardous wastes having Waste Programs; and CERCLA SUPPLEMENTARY INFORMATION: This rule the characteristics identified under, or Hazardous Substance Designation and is available on the Internet. Please listed pursuant to, RCRA section 3001 Reportable Quantities follow these instructions to access the (except when suspended by Congress) AGENCY: Environmental Protection rule electronically: From the World become hazardous substances under Agency (EPA). Wide Web (WWW), type http:// section 101(14)(C) of CERCLA, 42 U.S.C. -
Enzymologic and Metabolic Studies in Two Families Affected by Argininosuccinic Aciduria
Pediat. Res. 12: 256-262 (1978) Argininosuccinic aciduria erythrocyte enzymes argininosuccinic acid lyase urea cycle disorder enzyme kinetics protein tolerance test Enzymologic and Metabolic Studies in Two Families Affected by Argininosuccinic Aciduria I. A. QURESHI. J. LETARTE,'*' R. OUELLET, AND B. LEMIEUX Centre de Recherche Pidiatrique, Hbpital Sainfe-Justine and Universiti de Montrial, Monfrial; Diparternent de Pidiatrie, Centre Hospitalier Universitaire, UniversitP de Sherbrooke, Quebec, Canada Summaw Familial studies on argininosuccinic aciduria have also generally employed ASAL activity measurements in red blood cells. It has Both the affected families studied provide another example of been possible to identify the heterozygous or normal relatives of the autosomal recessive inheritance of argininosuccinic aciduria. the patient on the basis of the level of active enzyme in The fasting plasma levels of argininosuccinic acid in the two erythrocytes (5,7,8,14-17,21,22,25,30,35). propositi did not correlate with the levels of argininosuccinic As a part of the Quebec Network of Genetic Medicine acid lyase (ASAL) in erythrocytes. There was 210 pM argin- program in 1973 we studied two families of French-Canadian inosuccinic acid with indications of anhydride B content in the origin in which, on routine neonatal screening, one child in each family 1 propositus, having an enzyme activity of W%; while was discovered to excrete argininosuccinic acid. The diagnosis the family I1 propositus gave an argininosuccinic acidemia was confirmed by follow-up studies and erythrocyte enzyme reading of 64.6 pM with no activity of RBC ASAL. There was measurement in early 1975. This paper describes the results of a reduced enzyme activity in all the members of affected the familial biochemical, nutritional, and enzymologic studies families due to a signir~cantlyreduced V,,, value as compared undertaken recently.